A Renaissance for Psychedelics Could Fill a Long-Standing Treatment Gap for Psychiatric Disorders

Psilocybin and MDMA represent a first wave of therapies that help patients by changing the way they view reality

Previous
Previous

TGA Update (30 September 2021)

Next
Next

The worldview-changing drugs poised to go mainstream